Complement activation-related pseudoallergy in dogs following intravenous administration of a liposomal formulation of meglumine antimoniate
The increasing use of nanotechnologies in advanced therapies has allowed the observation of specific adverse reactions related Game to nanostructures.The toxicity of a novel liposome formulation of meglumine antimoniate in dogs with visceral leishmaniasis after single dose has been investigated.Groups of 12 animals received by the intravenous route